Skip to main content

Table 2 Blood lipid profile at baseline and 12 months of intervention

From: Effect of individual- versus collective-based nutritional-lifestyle intervention on the atherogenic index of plasma in children with obesity: a randomized trial

Variable

Individual intervention (n = 76)

Collective intervention

(n = 77)

p-value

Total cholesterol (mmol/L)

 Baseline

4.40 (4.20 to 4.60)

4.01 (3.80 to 4.21)

0.015

 12 months

4.20 (4.00 to 4.40)

3.92 (3.73 to 4.11)

0.007

 p-value†

0.001

0.108

 

LDL cholesterol (mmol/L)

 Baseline

2.58 (2.42 to 2.74)

2.42 (2.21 to 2.62)

0.030

 12 months

2.50 (2.32 to 2.68)

2.25 (2.05 to 2.45)

0.012

 p-value

0.023

 < 0.001

 

HDL cholesterol (mmol/L)

 Baseline

1.29 (1.23 to 1.35)

1.24 (1.18 to 1.30)

0.161

 12 months

1.32 (1.26 to 1.38)

1.25 (1.19 to 1.31)

0.142

 p-value

0.117

0.413

 

Triglycerides (mmol/L)

 Baseline

1.19 (1.07 to 1.31)

1.10 (0.97 to 1.23)

0.126

 12 months

0.90 (0.82 to 0.98)

0.95 (0.86 to 1.04)

0.548

 p-value

 < 0.001

0.021

 

Apo A1 (g/L)

 Baseline

1.33 (1.28 to 1.38)

1.37 (1.29 to 1.45)

0.663

 12 months

1.33 (1.28 to 1.38)

1.35 (1.31 to 1.39)

0.310

 p-value

0.978

0.193

 

Apo B (g/L)

 Baseline

0.76 (0.71 to 0.81)

0.76 (0.70 to 0.82)

0.496

 12 months

0.75 (0.70 to 0.80)

0.73 (0.68 to 0.78)

0.269

 p-value

0.892

0.322

 

AIP

 Baseline

0.29 (0.23 to 0.35)

0.27 (0.21 to 0.33)

0.463

 12 months

0.17 (0.12 to 0 to 22)

0.22 (0.17 to 0.27)

0.230

 p-value†

 < 0.001

0.100

 
  1. Values are mean (95% CI)
  2. LDL low to density to lipoprotein, HDL high to density to lipoprotein; Apo A1 apolipoprotein A1, Apo B apolipoprotein B, AIP atherogenic index of plasma